Morocco vs Togo: Statin use vs. average non-HDL cholesterol levels

Morocco

2.8

in 2018

Togo

2.8

in 2018

Morocco rank

163rd

Togo rank

163rd

Statin use vs. average non-HDL cholesterol levels over time

Morocco
Togo

How they compare

Morocco currently reports 2.8 against 2.8 in Togo, a difference of 0.

The two have swapped places 1 time across 39 shared years of data; in 1980 it was Morocco ahead.

Morocco ranks 163rd and Togo ranks 163rd of 191 countries.

Individual pages

About this data

Indicator: Statin use vs. average non-HDL cholesterol levels
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 191 places, 7,449 data points, 1980–2018
Last refreshed: 07 August 2026

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.